These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15080158)

  • 1. [Non-alcoholic fatty liver: the hepatologic stakes and the metabolic stakes].
    Traverso M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):478-80. PubMed ID: 15080158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
    Malnick SD; Beergabel M; Knobler H
    QJM; 2003 Oct; 96(10):699-709. PubMed ID: 14500857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis].
    Fraenkel E; Takács R; Hamvas J; Lengyel G; Fehér J
    Orv Hetil; 2007 Apr; 148(17):793-8. PubMed ID: 17452309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NASH/NAFLD management.
    James OF
    Acta Gastroenterol Belg; 2002; 65(4):200-3. PubMed ID: 12619426
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC; Chitturi S; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a focal lesion in the liver. answer to the clinical challenges and images in GI question: image 3: Focal fatty infiltration.
    Tharayil V; Roberts LR
    Gastroenterology; 2010 Aug; 139(2):e10-1. PubMed ID: 20600054
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-alcoholic liver disease (NASH)].
    Maier KP
    Praxis (Bern 1994); 2006 Aug; 95(34):1267-9. PubMed ID: 16956020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abdominal obesity: metabolic complications and consequences for the liver].
    Oldenburg B; Pijl H
    Ned Tijdschr Geneeskd; 2001 Jul; 145(27):1290-4. PubMed ID: 11475019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic steatohepatitis: another disease of affluence.
    James O; Day C
    Lancet; 1999 May; 353(9165):1634-6. PubMed ID: 10335777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disturbances of lipid metabolism and fatty liver].
    Mach T
    Przegl Lek; 1999; 56(3):205-10. PubMed ID: 10442010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.
    van Werven JR; Schreuder TC; Nederveen AJ; Lavini C; Jansen PL; Stoker J
    Eur J Radiol; 2010 Aug; 75(2):e102-7. PubMed ID: 20116951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease.
    Tuyama AC; Chang CY
    J Diabetes; 2012 Sep; 4(3):266-80. PubMed ID: 22564417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 17. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An update on non-alcoholic fatty liver disease].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Rev Invest Clin; 2004; 56(1):72-82. PubMed ID: 15144045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease.
    Fitzgerald MA
    Nurse Pract; 2007 Feb; 32(2):24-5. PubMed ID: 17264787
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in children.
    Janczyk W; Socha P
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):297-300. PubMed ID: 22521558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.